Enzalutamide Alternatives Compared
| Enzalutamide | Erleada (apalutamide) | Bicalutamide |
|
|---|
| Enzalutamide | Erleada (apalutamide) | Bicalutamide |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Prostate Cancer. Enzalutamide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Prostate Cancer. Erleada may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Prostate Cancer. Bicalutamide may also be used for purposes not listed in this medication guide. |
Related suggestions Prostate Cancer
|
|||||||||||||||
| More about Enzalutamide | More about Erleada (apalutamide) | More about Bicalutamide | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Enzalutamide has an average rating of 5.8 out of 10 from a total of 22 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 43% reported a negative effect. |
Erleada has an average rating of 7.4 out of 10 from a total of 17 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 12% reported a negative effect. |
Bicalutamide has an average rating of 8.2 out of 10 from a total of 12 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Erleada prices |
View all Bicalutamide prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Xtandi |
N/A |
Casodex | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
244.8 hours |
72 hours |
240 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 659 drugs are known to interact with Enzalutamide:
|
A total of 628 drugs are known to interact with Erleada:
|
A total of 374 drugs are known to interact with Bicalutamide:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
August 31, 2012 |
February 14, 2018 |
October 04, 1995 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.